Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Wellgistics Health (WGRX) Gross Profit (2024 - 2025)

Wellgistics Health filings provide 2 years of Gross Profit readings, the most recent being -$7.9 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 729.13% to -$7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.4 million, a N/A change, with the full-year FY2025 number at -$6.4 million, down 463.63% from a year prior.
  • Gross Profit hit -$7.9 million in Q4 2025 for Wellgistics Health, down from $231012.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.2 million in Q4 2024 to a low of -$7.9 million in Q4 2025.